Summary

The patient experience technology market is projected to reach USD 1.16 billion by 2030 from USD 0.66 billion in 2025, at a CAGR of 11.8%. This growth is driven by increasing expectations for convenience and personalization (appointment scheduling, digital check-in, teletriage), regulatory pushes for patient access/interoperability, and rapid adoption of AI, ambient analytics, and conversational interfaces that automate administrative tasks and surface actionable insights from patient feedback and encounter data.

https://mnmimg.marketsandmarkets.com/Images/patient-experience-technology-market-new-overview.webp

Vendors are increasingly integrating AI across patient experience platforms. For instance, in December 2023, Qualtrics announced a collaboration with Epic to integrate patient experience data directly into Epic’s comprehensive health record (CHR) system. The partnership leverages Qualtrics’ AI and natural language processing to fuse clinical and experiential data, enabling providers to deliver more personalized, empathetic care. The integration allows frontline staff to detect and act on patient sentiment, such as frustrations with scheduling, in real time, enhancing responsiveness and care outcomes.
Thus, such developments demonstrate that combining clinical and experiential data can drive more responsive and outcomes-focused patient care.
The cloud-based segment is expected to witness significant market share during the forecast period.
Based on the offering, the patient experience technology market is segmented into software/platform and services. The software segment is divided into on-premise, cloud-based, and hybrid. The cloud-based platform is expected to witness significant market growth during the forecast period due to its scalability, lower upfront costs, and ability to rapidly deploy updates. Healthcare providers increasingly favor cloud solutions for digital check-ins, telehealth triage, patient portals, and AI-driven personalization. Vendors such as Press Ganey, Qualtrics, and Epic are embedding cloud-native analytics, conversational AI, and ambient listening tools that improve flexibility and care access. In February 2025, Press Ganey partnered with Microsoft to develop generative AI-powered solutions that combine Press Ganey’s dataset of over 7.6 billion patient encounters with Microsoft’s AI, cloud, and ambient listening tools. This collaboration enables predictive analytics for patient safety, real-time actionable insights for providers, and secure data sharing via Azure, demonstrating that cloud-based PX platforms are driving personalization, efficiency, and improved patient experience.
Hence, such strategic collaborations underscore the growing role of cloud-based, AI-enabled patient experience platforms in delivering personalized, efficient, and data-driven care across healthcare settings.

The healthcare payers segment is expected to grow at a considerable CAGR during the forecast period.
By end user, the healthcare payers segment is expected to register the highest CAGR during the forecast period. Payers are increasingly investing in patient experience (PX) platforms to improve member engagement, streamline claims and administrative processes, and enhance overall satisfaction with health plan services. The growing emphasis on value-based care and outcomes-driven reimbursement models is prompting payers to leverage AI, analytics, and patient feedback tools to monitor service quality, predict member needs, and reduce preventable gaps in care.
Digital channels, such as member portals, teletriage, and automated communication tools, are being adopted to provide personalized, real-time support, improve adherence to preventive care, and strengthen patient loyalty. Additionally, regulatory mandates for interoperability and patient access, such as the US Cures Act and Europe’s EHDS, are accelerating payer adoption of patient experience technologies. As a result, payers are emerging as a key growth driver in the market, reflecting their strategic focus on member experience and outcomes.


Europe is expected to lead the patient experience technology market in 2025.

During the forecast period, Europe is projected to hold a substantial share of the global patient experience technology market, driven by the widespread adoption of digital health technologies, rising demand for patient-centered care, and a robust regulatory environment that prioritizes data privacy and interoperability. A major trend is the shift toward personalized healthcare, with platforms and tools designed to tailor interventions to individual patient needs, enhancing adherence, satisfaction, and clinical outcomes. Governments, healthcare authorities, and public-private partnerships are playing a pivotal role in promoting patient involvement across the healthcare ecosystem. For instance, in March 2022, the European Health Initiative, a flagship public-private collaboration in life sciences with a USD 2.46 billion budget, established a Science & Innovation Panel that actively integrates patients in every stage of research, ensuring that healthcare solutions reflect real-world patient priorities.
In addition, the European Union’s eHealth and Digital Decade initiatives are driving widespread adoption of electronic health records (EHRs), patient portals, and interoperable health systems, creating a fertile environment for patient engagement technologies. For instance, in July 2024, the European Commission released the Digital Decade 2024 study, highlighting progress toward universal access to electronic health records (EHRs) for EU citizens by 2030. The report noted that the EU27-average composite score for eHealth maturity increased from 72% to 79% in 2023, with 22 member states improving their performance.
Digital tools such as mobile health apps, telehealth platforms, AI-driven virtual assistants, and remote monitoring devices are increasingly being integrated into clinical workflows to improve communication, monitor treatment adherence, and support preventive care. Notable European vendors such as Doctrin (Sweden), Infermedica (Poland), and Cegedim (France) are actively expanding their patient engagement offerings, providing cloud-based, AI-enabled solutions that enable hospitals, clinics, and payers to enhance patient experience and operational efficiency.
These trends collectively signal that Europe will continue to be a leading region for patient engagement technology adoption, supported by ongoing government investments, regulatory incentives, and the increasing prioritization of patient empowerment in healthcare delivery.
The breakdown of primary participants is as mentioned below:
? By Company Type ? Tier 1: 45%, Tier 2: 30%, and Tier 3: 25%
? By Designation ? C Level: 42%, Director Level: 31%, and Others: 27%
? By Region ? North America: 35%, Europe: 30%, Asia Pacific: 25%, Middle East & Africa: 5%, Latin America: 5%

Key Players
The key players functioning in the patient experience technology market include Press Ganey (US), National Research Corporation (NRC Health) (US), Medallia Inc. (US), Phreesia (US), NiCE (Israel), R1 (US), Epic Systems Corporation (US), IQVIA (US), Qualtrics (US), Relias LLC (US), GetWellNetwork (US), CipherHealth Inc. (US), Kyruus, Inc. (US), Twilio Inc. (US), Relatient (US), Alida (Canada), Certify Health (US), Avaamo (US), Luma Health Inc. (US), Solutionreach (US), and Salesforce, Inc. (US).
Research Coverage
The report analyzes the patient experience technology market. It aims to estimate the market size and future growth potential of various market segments based on component, use case, revenue model, end user, and region. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will enrich established firms and new entrants/smaller firms to gauge the market's pulse, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.
This report provides insights on:
? Analysis of key drivers: Drivers (rising demand for digital engagement platforms and personalized patient care, increasing adoption of telehealth, mobile health apps, and AI-powered analytics, government initiatives and funding for healthcare digital transformation, growing focus on improving patient satisfaction and long-term engagement, and expansion of cloud-based engagement platforms), Restraints (data privacy and cybersecurity concerns, high implementation and integration costs for healthcare providers, limited interoperability between patient engagement systems and existing EHRs), Opportunities (growth opportunities in emerging markets, adoption of AI-driven personalization and predictive analytics for patient care, strategic partnerships among technology platforms, pharma companies, and payers, and rising adoption of virtual reality and augmented reality) and Challenges (need to ensure accuracy and reliability of feedback data, rapid technological evolution) influencing the growth of the patient experience technology market.
? Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the patient experience technology market.
? Market Development: Comprehensive information on the lucrative emerging markets, by offerings, functions, end user, and region
? Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the patient experience technology market.
? Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the patient experience technology market such as Press Ganey (US), National Research Corporation (NRC Health) (US), Medallia Inc. (US), Phreesia (US), NiCE (Israel), R1 (US), Epic Systems Corporation (US), IQVIA (US), Qualtrics (US), Relias LLC (US), GetWellNetwork (US), CipherHealth Inc. (US), Kyruus, Inc. (US), Twilio Inc. (US), Relatient (US), Alida (Canada), Certify Health (US), Avaamo (US), Luma Health Inc. (US), Solutionreach (US), Salesforce, Inc. (US), Vital (US), NexHealth (US), Collectly, Inc. (US), Business Integrity Services (US), and Bamboo Health (US).

ページTOPに戻る

Table of Contents

1 INTRODUCTION 30
1.1 STUDY OBJECTIVES 30
1.2 MARKET DEFINITION 30
1.3 STUDY SCOPE 31
1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE 31
1.3.2 INCLUSIONS AND EXCLUSIONS 32
1.3.3 YEARS CONSIDERED 33
1.4 CURRENCY CONSIDERED 33
1.5 STAKEHOLDERS 34
1.6 SUMMARY OF CHANGES 34
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH DATA 36
2.1.1 SECONDARY DATA 37
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Key data from primary sources 39
2.1.2.2 Breakdown of primary sources 40
2.2 RESEARCH METHODOLOGY 41
2.3 MARKET SIZE ESTIMATION 42
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 49
2.5 RESEARCH ASSUMPTIONS 50
2.5.1 PARAMETRIC ASSUMPTIONS 50
2.5.2 OVERALL STUDY ASSUMPTIONS 50
2.6 RESEARCH LIMITATIONS 51
2.6.1 METHODOLOGY-RELATED LIMITATIONS 51
2.6.2 SCOPE-RELATED LIMITATIONS 51
2.7 RISK ANALYSIS 51
3 EXECUTIVE SUMMARY 52
4 PREMIUM INSIGHTS 57
4.1 PATIENT EXPERIENCE TECHNOLOGY MARKET OVERVIEW 57
4.2 NORTH AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET,
BY OFFERING AND REGION 58
4.3 PATIENT EXPERIENCE TECHNOLOGY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 59
4.4 PATIENT EXPERIENCE TECHNOLOGY MARKET: DEVELOPED VS. EMERGING ECONOMIES 60
?
5 MARKET OVERVIEW 61
5.1 INTRODUCTION 61
5.2 MARKET DYNAMICS 61
5.2.1 DRIVERS 62
5.2.1.1 Rising demand for digital engagement platforms and personalized patient care 62
5.2.1.2 Increasing adoption of telehealth, mobile health apps, and
AI-powered analytics 63
5.2.1.3 Government initiatives and funding for healthcare digital transformation 64
5.2.1.4 Growing focus on improving patient satisfaction and long-term engagement 64
5.2.1.5 Expansion of cloud-based engagement platforms 65
5.2.2 RESTRAINTS 66
5.2.2.1 Data privacy and cybersecurity concerns 66
5.2.2.2 High implementation and integration costs for healthcare providers 66
5.2.2.3 Limited interoperability between patient engagement systems and existing electronic health record systems 67
5.2.3 OPPORTUNITIES 67
5.2.3.1 Growth opportunities in emerging market 67
5.2.3.2 Adoption of AI-driven personalization and predictive analytics for patient care 67
5.2.3.3 Strategic partnerships among technology providers, pharma companies, and payers 68
5.2.3.4 Rising adoption of virtual reality and augmented reality 69
5.2.4 CHALLENGES 69
5.2.4.1 Need to ensure accuracy and reliability of feedback data 69
5.2.4.2 Rapid technological evolution 69
5.3 INDUSTRY TRENDS 70
5.3.1 INVESTMENTS IN PATIENT ENGAGEMENT AND EXPERIENCE PLATFORMS 70
5.3.2 AI-DRIVEN PERSONALIZATION AND VIRTUAL ASSISTANTS 70
5.3.3 CLOUD-BASED PLATFORMS AND OMNICHANNEL ACCESS 70
5.3.4 TELEHEALTH AND HYBRID CARE MODELS 70
5.3.5 IMMERSIVE TECHNOLOGIES FOR EDUCATION AND ADHERENCE 71
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 71
5.5 PRICING ANALYSIS 72
5.5.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER 72
5.5.2 AVERAGE SELLING PRICE TREND, BY REGION 73
5.6 VALUE CHAIN ANALYSIS 74
5.7 ECOSYSTEM ANALYSIS 75
5.8 INVESTMENT AND FUNDING SCENARIO 78
5.9 TECHNOLOGY ANALYSIS 78
?
5.9.1 KEY TECHNOLOGIES 78
5.9.1.1 Voice-of-the-Patient (VoP) platforms 78
5.9.1.2 Telehealth and virtual care platforms 79
5.9.1.3 Patient portals and personal health records 79
5.9.1.4 Remote Patient Monitoring (RPM) 79
5.9.2 COMPLEMENTARY TECHNOLOGIES 79
5.9.2.1 Interoperability/API and FHIR Infrastructure 79
5.9.2.2 Patient identity management and authentication systems 80
5.9.3 ADJACENT TECHNOLOGIES 80
5.9.3.1 Clinical Decision Support Systems (CDSS) 80
5.9.3.2 Population Health Management (PHM) platforms 80
5.9.3.3 Patient engagement solutions 80
5.10 PATENT ANALYSIS 81
5.10.1 PATENT PUBLICATION TRENDS 81
5.10.2 JURISDICTION ANALYSIS 82
5.10.3 MAJOR PATENTS IN PATIENT EXPERIENCE TECHNOLOGY MARKET 83
5.11 KEY CONFERENCES AND EVENTS, 2025?2027 85
5.12 CASE STUDY ANALYSIS 86
5.13 REGULATORY LANDSCAPE 88
5.13.1 REGULATORY ANALYSIS 88
5.13.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 91
5.14 PORTER’S FIVE FORCES ANALYSIS 98
5.14.1 BARGAINING POWER OF SUPPLIERS 99
5.14.2 BARGAINING POWER OF BUYERS 99
5.14.3 THREAT OF NEW ENTRANTS 99
5.14.4 THREAT OF SUBSTITUTES 99
5.14.5 INTENSITY OF COMPETITIVE RIVALRY 100
5.15 KEY STAKEHOLDERS AND BUYING CRITERIA 100
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS 100
5.15.2 KEY BUYING CRITERIA 101
5.16 END-USER ANALYSIS 102
5.16.1 UNMET NEEDS 102
5.16.2 END-USER EXPECTATIONS 103
5.17 BUSINESS MODELS 103
5.18 IMPACT OF AI/GEN AI ON PATIENT EXPERIENCE TECHNOLOGY MARKET 104
5.18.1 INTRODUCTION 104
5.18.2 MARKET POTENTIAL OF AI IN PATIENT EXPERIENCE TECHNOLOGY 104
5.18.3 AI USE CASES 105
5.18.4 CASE STUDY ON IMPLEMENTATION OF AI/GEN AI 106
5.18.5 INTERCONNECTED AND ADJACENT ECOSYSTEMS 107
?
5.18.5.1 US healthcare technology market 107
5.18.5.2 Patient engagement technology market 108
5.18.6 USER READINESS AND IMPACT ASSESSMENT 109
5.18.6.1 User readiness 109
5.18.6.1.1 Hospitals & health systems 109
5.18.6.1.2 Outpatient & ambulatory care centers 109
5.18.6.1.3 Physician and group practices 109
5.18.6.1.4 Long-term care and post-acute facilities 109
5.18.6.1.5 Others 109
5.18.6.2 Impact assessment 109
5.18.6.2.1 Implementation 109
5.18.6.2.2 Impact 110
5.19 IMPACT OF 2025 US TARIFFS ON PATIENT EXPERIENCE TECHNOLOGY MARKET 110
5.19.1 INTRODUCTION 110
5.19.2 KEY TARIFF RATES 110
5.19.3 IMPACT ON COUNTRY/REGION 111
5.19.3.1 US 111
5.19.3.2 Europe 111
5.19.3.3 Asia Pacific 111
5.19.4 IMPACT ON END-USE INDUSTRIES 112
5.19.4.1 Healthcare providers 112
5.19.4.2 Healthcare payers 112
5.19.4.3 Pharma & biotech companies 113
5.19.4.4 Others 113
6 PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING 114
6.1 INTRODUCTION 115
6.2 SOFTWARE 115
6.2.1 ON-PREMISE SOFTWARE 117
6.2.1.1 Data sovereignty and seamless workflow ability to drive market 117
6.2.2 CLOUD-BASED SOFTWARE 118
6.2.2.1 Lower upfront costs and seamless interoperability to aid growth 118
6.2.3 HYBRID SOFTWARE 119
6.2.3.1 Ability to ensure maximum compliance and control to boost market 119
6.3 SERVICES 121
6.3.1 MANAGED SERVICES 122
6.3.1.1 Rising demand for operational efficiency and risk mitigation to encourage growth 122
6.3.2 PROFESSIONAL SERVICES 123
6.3.2.1 Need for continuous patient engagement to contribute to growth 123
?
7 PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION 125
7.1 INTRODUCTION 126
7.2 APPOINTMENT SCHEDULING 126
7.2.1 GROWING TREND TOWARD OMNICHANNEL, INTELLIGENT PATIENT EXPERIENCE SOLUTIONS TO FUEL MARKET 126
7.3 PATIENT REGISTRATION 128
7.3.1 NEED TO ENHANCE CLINICAL SAFETY AND OPERATIONAL PERFORMANCE TO AUGMENT GROWTH 128
7.4 VIRTUAL CARE 129
7.4.1 EXPANDING REMOTE ACCESS AND CONTINUITY OF CARE TO AID GROWTH 129
7.5 PATIENT COMMUNICATION 131
7.5.1 INCREASING LAUNCHES OF COMMUNICATION PLATFORMS TO BOLSTER GROWTH 131
7.6 BILLING 133
7.6.1 INCREASING PUSH FOR TRANSPARENT AND AUTOMATED FINANCIAL WORKFLOWS TO SPUR GROWTH 133
7.7 FEEDBACK MANAGEMENT 134
7.7.1 NEED FOR REAL-TIME INSIGHTS INTO PATIENT SATISFACTION, CARE QUALITY, AND SERVICE GAPS TO FACILITATE GROWTH 134
7.8 OTHER FUNCTIONS 136
8 PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER 137
8.1 INTRODUCTION 138
8.2 HEALTHCARE PROVIDERS 139
8.2.1 HOSPITALS & HEALTH SYSTEMS 140
8.2.1.1 Growing adoption of advanced digital and AI-driven platforms to bolster market 140
8.2.2 OUTPATIENT & AMBULATORY CARE CENTERS 142
8.2.2.1 Rising demand for preventive care, chronic disease management, and same-day procedures to promote growth 142
8.2.3 PHYSICIANS & GROUP PRACTICES 143
8.2.3.1 Increasing use of predictive analytics and remote monitoring tools to augment growth 143
8.2.4 LONG-TERM CARE & POST-ACUTE FACILITIES 145
8.2.4.1 Growing burden of aging population and chronic diseases to boost market 145
8.2.5 OTHER HEALTHCARE PROVIDERS 147
8.3 HEALTHCARE PAYERS 148
8.3.1 INCREASING ADVANCEMENTS IN ARTIFICIAL INTELLIGENCE AND VIRTUAL CARE MODELS TO FUEL MARKET 148
8.4 PHARMA & BIOTECH COMPANIES 149
8.4.1 RISING INTEGRATION OF PATIENT EXPERIENCE TECHNOLOGY TO AID GROWTH 149
8.5 OTHER END USERS 150
?
9 PATIENT EXPERIENCE TECHNOLOGY MARKET, BY REGION 152
9.1 INTRODUCTION 153
9.2 NORTH AMERICA 154
9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 155
9.2.2 US 158
9.2.2.1 Increasing adoption of digital solutions to contribute to growth 158
9.2.3 CANADA 161
9.2.3.1 Rising focus on healthcare delivery through digital innovation to expedite growth 161
9.3 EUROPE 164
9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 164
9.3.2 UK 168
9.3.2.1 Growing focus on digital-first healthcare delivery and patient empowerment to drive market 168
9.3.3 GERMANY 171
9.3.3.1 Aging population and rising prevalence of chronic diseases to spur growth 171
9.3.4 FRANCE 174
9.3.4.1 Favorable policies and commitment to digital transformation to aid growth 174
9.3.5 ITALY 177
9.3.5.1 Expanding regulatory and reimbursement support to fuel market 177
9.3.6 SPAIN 180
9.3.6.1 Growing adoption of telemedicine to boost market 180
9.3.7 REST OF EUROPE 183
9.4 ASIA PACIFIC 186
9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 187
9.4.2 JAPAN 190
9.4.2.1 Rapidly growing elderly population to accelerate growth 190
9.4.3 CHINA 194
9.4.3.1 Widespread integration of healthcare services into super-apps to accelerate growth 194
9.4.4 INDIA 197
9.4.4.1 Increasing burden of non-communicable diseases and use of mobile-first platforms to favor growth 197
9.4.5 SOUTH KOREA 200
9.4.5.1 Booming medical tourism to speed up growth 200
9.4.6 AUSTRALIA 203
9.4.6.1 Matured healthcare system and digital infrastructure to promote growth 203
9.4.7 REST OF ASIA PACIFIC 206
9.5 LATIN AMERICA 209
9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 210
9.5.2 BRAZIL 213
9.5.2.1 Increase utilization of digital ecosystems to spur growth 213
9.5.3 MEXICO 216
9.5.3.1 Growing consumer-driven digital marketplaces to fuel market 216
9.5.4 REST OF LATIN AMERICA 219
9.6 MIDDLE EAST & AFRICA 222
9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 222
9.6.2 GCC COUNTRIES 226
9.6.2.1 Rising healthcare investments to contribute to growth 226
9.6.2.2 Saudi Arabia 229
9.6.2.2.1 Digital health transformation programs to support growth 229
9.6.2.3 UAE 232
9.6.2.3.1 Rising patient expectations and entry of innovative regional platforms to aid growth 232
9.6.2.4 Rest of GCC countries 235
9.6.3 SOUTH AFRICA 238
9.6.3.1 Growing smartphone penetration and supportive regulatory efforts to boost market 238
9.6.4 REST OF MIDDLE EAST & AFRICA 240
10 COMPETITIVE LANDSCAPE 244
10.1 OVERVIEW 244
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 244
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PATIENT EXPERIENCE TECHNOLOGY MARKET 244
10.3 REVENUE ANALYSIS, 2020?2024 246
10.4 MARKET SHARE ANALYSIS, 2024 247
10.5 COMPANY VALUATION AND FINANCIAL METRICS 250
10.6 BRAND/SOFTWARE COMPARISON 251
10.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 252
10.7.1 STARS 252
10.7.2 EMERGING LEADERS 252
10.7.3 PERVASIVE PLAYERS 252
10.7.4 PARTICIPANTS 252
10.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 254
10.7.5.1 Company footprint 254
10.7.5.2 Region footprint 255
10.7.5.3 Offering footprint 256
10.7.5.4 Function footprint 257
10.7.5.5 End-user footprint 258
10.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 259
10.8.1 PROGRESSIVE COMPANIES 259
10.8.2 RESPONSIVE COMPANIES 259
10.8.3 DYNAMIC COMPANIES 259
10.8.4 STARTING BLOCKS 259
10.8.5 COMPETITIVE BENCHMARKING OF STARTUPS/SMES, 2024 261
10.8.5.1 Detailed list of key startups/SMEs 261
10.8.5.2 Competitive benchmarking of key startups/SMEs 261
10.9 COMPETITIVE SCENARIO 262
10.9.1 SOLUTION LAUNCHES AND ENHANCEMENTS 262
10.9.2 DEALS 263
10.9.3 EXPANSIONS 264
11 COMPANY PROFILES 265
11.1 KEY PLAYERS 265
11.1.1 PRESS GANEY 265
11.1.1.1 Business overview 265
11.1.1.2 Solutions offered 265
11.1.1.3 Recent developments 266
11.1.1.3.1 Solution launches and enhancements 266
11.1.1.3.2 Deals 266
11.1.1.4 MnM view 267
11.1.1.4.1 Right to win 267
11.1.1.4.2 Strategic choices 267
11.1.1.4.3 Weaknesses and competitive threats 267
11.1.2 NATIONAL RESEARCH CORPORATION 268
11.1.2.1 Business overview 268
11.1.2.2 Solutions offered 269
11.1.2.3 Recent developments 269
11.1.2.3.1 Solution launches and enhancements 269
11.1.2.4 MnM view 270
11.1.2.4.1 Right to win 270
11.1.2.4.2 Strategic choices 270
11.1.2.4.3 Weaknesses and competitive threats 270
11.1.3 MEDALLIA INC. 271
11.1.3.1 Business overview 271
11.1.3.2 Solutions offered 271
11.1.3.3 Recent developments 272
11.1.3.3.1 Solution launches and enhancements 272
11.1.3.3.2 Deals 272
11.1.3.4 MnM view 273
11.1.3.4.1 Right to win 273
11.1.3.4.2 Strategic choices 273
11.1.3.4.3 Weaknesses and competitive threats 273
?
11.1.4 PHREESIA 274
11.1.4.1 Business overview 274
11.1.4.2 Solutions offered 275
11.1.4.3 Recent developments 276
11.1.4.3.1 Solution launches and enhancements 276
11.1.4.3.2 Deals 276
11.1.4.4 MnM view 277
11.1.4.4.1 Right to win 277
11.1.4.4.2 Strategic choices 277
11.1.4.4.3 Weaknesses and competitive threats 277
11.1.5 NICE 278
11.1.5.1 Business overview 278
11.1.5.2 Solutions offered 279
11.1.5.3 MnM view 280
11.1.5.3.1 Right to win 280
11.1.5.3.2 Strategic choices 280
11.1.5.3.3 Weaknesses and competitive threats 280
11.1.6 R1 281
11.1.6.1 Business overview 281
11.1.6.2 Solutions offered 281
11.1.6.3 Recent developments 282
11.1.6.3.1 Solution launches and enhancements 282
11.1.6.3.2 Deals 282
11.1.7 EPIC SYSTEMS CORPORATION 283
11.1.7.1 Business overview 283
11.1.7.2 Solutions offered 283
11.1.7.3 Recent developments 284
11.1.7.3.1 Solution launches and enhancements 284
11.1.7.3.2 Deals 284
11.1.8 IQVIA 285
11.1.8.1 Business overview 285
11.1.8.2 Solutions offered 286
11.1.8.3 Recent developments 287
11.1.8.3.1 Solution launches and enhancements 287
11.1.9 QUALTRICS 288
11.1.9.1 Business overview 288
11.1.9.2 Solutions offered 288
11.1.9.3 Recent developments 289
11.1.9.3.1 Deals 289
11.1.9.3.2 Expansions 290
11.1.9.3.3 Other developments 290
?
11.1.10 RELIAS LLC 291
11.1.10.1 Business overview 291
11.1.10.2 Solutions offered 291
11.1.10.3 Recent developments 292
11.1.10.3.1 Deals 292
11.1.11 GETWELLNETWORK, INC. 293
11.1.11.1 Business overview 293
11.1.11.2 Solutions offered 293
11.1.11.3 Recent developments 294
11.1.11.3.1 Solution launches and enhancements 294
11.1.11.3.2 Deals 294
11.1.12 CIPHERHEALTH INC. 295
11.1.12.1 Business overview 295
11.1.12.2 Solutions offered 295
11.1.12.3 Recent developments 296
11.1.12.3.1 Solution launches and enhancements 296
11.1.12.3.2 Deals 296
11.1.13 KYRUUS, INC. 297
11.1.13.1 Business overview 297
11.1.13.2 Solutions offered 297
11.1.13.3 Recent developments 298
11.1.13.3.1 Solution launches and enhancements 298
11.1.13.3.2 Deals 299
11.1.14 RELATIENT 300
11.1.14.1 Business overview 300
11.1.14.2 Solutions offered 300
11.1.14.3 Recent developments 301
11.1.14.3.1 Solution launches and enhancements 301
11.1.15 ALIDA 302
11.1.15.1 Business overview 302
11.1.15.2 Solutions offered 302
11.1.15.3 Recent developments 303
11.1.15.3.1 Other developments 303
11.1.16 TWILIO INC. 304
11.1.16.1 Business overview 304
11.1.16.2 Solutions offered 306
11.1.16.3 Recent developments 306
11.1.16.3.1 Solution launches and enhancements 306
11.1.16.3.2 Deals 307
11.1.17 AVAAMO 308
11.1.17.1 Business overview 308
11.1.17.2 Solutions offered 308
11.1.17.3 Recent developments 309
11.1.17.3.1 Solution launches and enhancements 309
11.1.18 CERTIFY HEALTH 310
11.1.18.1 Business overview 310
11.1.18.2 Solutions offered 310
11.1.18.3 Recent developments 311
11.1.18.3.1 Other developments 311
11.1.19 LUMA HEALTH INC. 312
11.1.19.1 Business overview 312
11.1.19.2 Solutions offered 312
11.1.19.3 Recent developments 313
11.1.19.3.1 Solution launches and enhancements 313
11.1.19.3.2 Deals 314
11.1.20 SOLUTIONREACH 315
11.1.20.1 Business overview 315
11.1.20.2 Solutions offered 315
11.1.20.3 Recent developments 316
11.1.20.3.1 Solution launches and enhancements 316
11.1.21 SALESFORCE, INC. 317
11.1.21.1 Business overview 317
11.1.21.2 Solutions offered 318
11.1.21.3 Recent developments 320
11.1.21.3.1 Solution launches and enhancements 320
11.2 OTHER PLAYERS 321
11.2.1 VITAL 321
11.2.2 NEXHEALTH 322
11.2.3 COLLECTLY, INC. 323
11.2.4 BUSINESS INTEGRITY SERVICES 324
11.2.5 BAMBOO HEALTH 325
12 APPENDIX 326
12.1 DISCUSSION GUIDE 326
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 331
12.3 CUSTOMIZATION OPTIONS 333
12.4 RELATED REPORTS 333
12.5 AUTHOR DETAILS 334

ページTOPに戻る

List of Tables/Graphs

TABLE 1 PATIENT EXPERIENCE TECHNOLOGY MARKET: INCLUSIONS AND EXCLUSIONS 32
TABLE 2 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD, 2021?2024 33
TABLE 3 PATIENT EXPERIENCE TECHNOLOGY MARKET: FACTOR ANALYSIS 46
TABLE 4 PATIENT EXPERIENCE TECHNOLOGY MARKET: RISK ANALYSIS 51
TABLE 5 PATIENT EXPERIENCE TECHNOLOGY MARKET: IMPACT ANALYSIS OF
MARKET DYNAMICS 62
TABLE 6 AVERAGE SELLING PRICE TREND OF PATIENT EXPERIENCE SOFTWARE,
BY KEY PLAYER, 2022?2025 (USD) 72
TABLE 7 AVERAGE SELLING PRICE TREND OF PATIENT EXPERIENCE TECHNOLOGY,
BY REGION, 2022?2025 (USD) 73
TABLE 8 PATIENT EXPERIENCE TECHNOLOGY MARKET:
ROLE OF COMPANIES IN ECOSYSTEM 77
TABLE 9 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR PATIENT EXPERIENCE TECHNOLOGY, 2015?2025 82
TABLE 10 PATIENT EXPERIENCE TECHNOLOGY MARKET: LIST OF PATENTS/PATENT APPLICATIONS, 2020?2025 84
TABLE 11 PATIENT EXPERIENCE TECHNOLOGY MARKET: KEY CONFERENCES
AND EVENTS, 2025?2027 85
TABLE 12 CASE STUDY 1: IMPROVED PATIENT-CENTERED CARE WITH DIGIVALET PATIENT EXPERIENCE PLATFORM 86
TABLE 13 CASE STUDY 2: PAPERLESS ADMISSIONS VIA PWC + SALESFORCE
DIGITAL PATIENT PORTAL 87
TABLE 14 CASE STUDY 3: TIMELY PATIENT COMMUNICATIONS WITH TWILIO MESSAGING 87
TABLE 15 CASE STUDY 4: DIGITAL WAYFINDING & WI-FI ENHANCEMENTS
BY WORLDWIDE TECHNOLOGY 88
TABLE 16 REGULATORY SCENARIO IN NORTH AMERICA 88
TABLE 17 REGULATORY SCENARIO IN EUROPE 89
TABLE 18 REGULATORY SCENARIO IN ASIA PACIFIC 90
TABLE 19 REGULATORY SCENARIO IN MIDDLE EAST & AFRICA 90
TABLE 20 REGULATORY SCENARIO IN LATIN AMERICA 91
TABLE 21 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 91
TABLE 22 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 94
TABLE 23 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 95
TABLE 24 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 97
TABLE 25 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 97
TABLE 26 PATIENT EXPERIENCE TECHNOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS 99
TABLE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP THREE
END USERS (%) 101
TABLE 28 KEY BUYING CRITERIA FOR TOP THREE END USERS 102
TABLE 29 PATIENT EXPERIENCE TECHNOLOGY MARKET: UNMET NEEDS 102
TABLE 30 PATIENT EXPERIENCE TECHNOLOGY MARKET: END-USER EXPECTATIONS 103
TABLE 31 CASE STUDY: AI-DRIVEN PATIENT EXPERIENCE ENHANCEMENT 106
TABLE 32 US ADJUSTED RECIPROCAL TARIFF RATES 110
TABLE 33 PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,
2023?2030 (USD MILLION) 115
TABLE 34 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE, BY TYPE,
2023?2030 (USD MILLION) 116
TABLE 35 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE, BY COUNTRY, 2023?2030 (USD MILLION) 116
TABLE 36 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR ON-PREMISE SOFTWARE,
BY COUNTRY, 2023?2030 (USD MILLION) 117
TABLE 37 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR CLOUD-BASED SOFTWARE,
BY COUNTRY, 2023?2030 (USD MILLION) 119
TABLE 38 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HYBRID SOFTWARE,
BY COUNTRY, 2023?2030 (USD MILLION) 120
TABLE 39 PATIENT EXPERIENCE TECHNOLOGY MARKET, BY SERVICE,
2023?2030 (USD MILLION) 121
TABLE 40 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY COUNTRY,
2023?2030 (USD MILLION) 122
TABLE 41 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR MANAGED SERVICES,
BY COUNTRY, 2023?2030 (USD MILLION) 123
TABLE 42 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR PROFESSIONAL SERVICES,
BY COUNTRY, 2023?2030 (USD MILLION) 124
TABLE 43 PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,
2023?2030 (USD MILLION) 126
TABLE 44 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR APPOINTMENT SCHEDULING,
BY COUNTRY, 2023?2030 (USD MILLION) 127
TABLE 45 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR PATIENT REGISTRATION,
BY COUNTRY, 2023?2030 (USD MILLION) 129
TABLE 46 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR VIRTUAL CARE, BY COUNTRY, 2023?2030 (USD MILLION) 130
TABLE 47 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR PATIENT COMMUNICATION,
BY COUNTRY, 2023?2030 (USD MILLION) 132
TABLE 48 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR BILLING, BY COUNTRY,
2023?2030 (USD MILLION) 134
TABLE 49 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR FEEDBACK MANAGEMENT,
BY COUNTRY, 2023?2030 (USD MILLION) 135
TABLE 50 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR OTHER FUNCTIONS,
BY COUNTRY, 2023?2030 (USD MILLION) 136
TABLE 51 PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,
2023?2030 (USD MILLION) 138
TABLE 52 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2023?2030 (USD MILLION) 139
TABLE 53 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS,
BY COUNTRY, 2023?2030 (USD MILLION) 140
TABLE 54 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HOSPITALS & HEALTH SYSTEMS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 141
TABLE 55 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR OUTPATIENT & AMBULATORY CARE CENTERS, BY COUNTRY, 2023?2030 (USD MILLION) 143
TABLE 56 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR PHYSICIANS & GROUP PRACTICES, BY COUNTRY, 2023?2030 (USD MILLION) 144
TABLE 57 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR LONG-TERM CARE & POST-ACUTE FACILITIES, BY COUNTRY, 2023?2030 (USD MILLION) 146
TABLE 58 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR OTHER HEALTHCARE PROVIDERS, BY COUNTRY, 2023?2030 (USD MILLION) 147
TABLE 59 PATIENT EXPERIENCE TECHNOLOGY FOR HEALTHCARE PAYERS, BY COUNTRY, 2023?2030 (USD MILLION) 149
TABLE 60 PATIENT EXPERIENCE TECHNOLOGY FOR PHARMA & BIOTECH COMPANIES,
BY COUNTRY, 2023?2030 (USD MILLION) 150
TABLE 61 PATIENT EXPERIENCE TECHNOLOGY FOR OTHER END USERS, BY COUNTRY,
2023?2030 (USD MILLION) 151
TABLE 62 PATIENT EXPERIENCE TECHNOLOGY MARKET, BY REGION,
2023?2030 (USD MILLION) 153
TABLE 63 NORTH AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 155
TABLE 64 NORTH AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2023?2030 (USD MILLION) 155
TABLE 65 NORTH AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE, BY TYPE, 2023?2030 (USD MILLION) 156
TABLE 66 NORTH AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES,
BY TYPE, 2023?2030 (USD MILLION) 156
TABLE 67 NORTH AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2023?2030 (USD MILLION) 157
TABLE 68 NORTH AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2023?2030 (USD MILLION) 157
TABLE 69 NORTH AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023?2030 (USD MILLION) 158
TABLE 70 US: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,
2023?2030 (USD MILLION) 159
TABLE 71 US: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE,
BY TYPE, 2023?2030 (USD MILLION) 159
TABLE 72 US: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE,
2023?2030 (USD MILLION) 159
TABLE 73 US: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,
2023?2030 (USD MILLION) 160
TABLE 74 US: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,
2023?2030 (USD MILLION) 160
TABLE 75 US: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023?2030 (USD MILLION) 161
TABLE 76 CANADA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,
2023?2030 (USD MILLION) 162
TABLE 77 CANADA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE,
BY TYPE, 2023?2030 (USD MILLION) 162
TABLE 78 CANADA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES,
BY TYPE, 2023?2030 (USD MILLION) 162
TABLE 79 CANADA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,
2023?2030 (USD MILLION) 163
TABLE 80 CANADA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,
2023?2030 (USD MILLION) 163
TABLE 81 CANADA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023?2030 (USD MILLION) 164
TABLE 82 EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 165
TABLE 83 EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,
2023?2030 (USD MILLION) 165
TABLE 84 EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE, BY TYPE, 2023?2030 (USD MILLION) 166
TABLE 85 EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2023?2030 (USD MILLION) 166
TABLE 86 EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,
2023?2030 (USD MILLION) 167
TABLE 87 EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,
2023?2030 (USD MILLION) 167
TABLE 88 EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023?2030 (USD MILLION) 168
TABLE 89 UK: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,
2023?2030 (USD MILLION) 169
TABLE 90 UK: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE, BY TYPE, 2023?2030 (USD MILLION) 169
TABLE 91 UK: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE,
2023?2030 (USD MILLION) 169
TABLE 92 UK: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,
2023?2030 (USD MILLION) 170
TABLE 93 UK: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,
2023?2030 (USD MILLION) 170
TABLE 94 UK: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023?2030 (USD MILLION) 171
TABLE 95 GERMANY: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,
2023?2030 (USD MILLION) 172
TABLE 96 GERMANY: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE,
BY TYPE, 2023?2030 (USD MILLION) 172
TABLE 97 GERMANY: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES,
BY TYPE, 2023?2030 (USD MILLION) 172
TABLE 98 GERMANY: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,
2023?2030 (USD MILLION) 173
TABLE 99 GERMANY: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,
2023?2030 (USD MILLION) 173
TABLE 100 GERMANY: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023?2030 (USD MILLION) 174
TABLE 101 FRANCE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,
2023?2030 (USD MILLION) 175
TABLE 102 FRANCE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE,
BY TYPE, 2023?2030 (USD MILLION) 175
TABLE 103 FRANCE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES,
BY TYPE, 2023?2030 (USD MILLION) 175
TABLE 104 FRANCE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,
2023?2030 (USD MILLION) 176
TABLE 105 FRANCE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,
2023?2030 (USD MILLION) 176
TABLE 106 FRANCE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023?2030 (USD MILLION) 177
TABLE 107 ITALY: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,
2023?2030 (USD MILLION) 178
TABLE 108 ITALY: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE, BY TYPE, 2023?2030 (USD MILLION) 178
TABLE 109 ITALY: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2023?2030 (USD MILLION) 178
TABLE 110 ITALY: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,
2023?2030 (USD MILLION) 179
TABLE 111 ITALY: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,
2023?2030 (USD MILLION) 179
TABLE 112 ITALY: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023?2030 (USD MILLION) 180
TABLE 113 SPAIN: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,
2023?2030 (USD MILLION) 181
TABLE 114 SPAIN: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE, BY TYPE, 2023?2030 (USD MILLION) 181
TABLE 115 SPAIN: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2023?2030 (USD MILLION) 181
TABLE 116 SPAIN: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,
2023?2030 (USD MILLION) 182
TABLE 117 SPAIN: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,
2023?2030 (USD MILLION) 182
TABLE 118 SPAIN: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023?2030 (USD MILLION) 183
TABLE 119 REST OF EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2023?2030 (USD MILLION) 184
TABLE 120 REST OF EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE, BY TYPE, 2023?2030 (USD MILLION) 184
TABLE 121 REST OF EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES,
BY TYPE, 2023?2030 (USD MILLION) 184
TABLE 122 REST OF EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2023?2030 (USD MILLION) 185
TABLE 123 REST OF EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2023?2030 (USD MILLION) 185
TABLE 124 REST OF EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023?2030 (USD MILLION) 186
TABLE 125 ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 188
TABLE 126 ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,
2023?2030 (USD MILLION) 188
TABLE 127 ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE,
BY TYPE, 2023?2030 (USD MILLION) 188
TABLE 128 ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES,
BY TYPE, 2023?2030 (USD MILLION) 189
TABLE 129 ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,
2023?2030 (USD MILLION) 189
TABLE 130 ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,
2023?2030 (USD MILLION) 190
TABLE 131 ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023?2030 (USD MILLION) 190
TABLE 132 JAPAN: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,
2023?2030 (USD MILLION) 191
TABLE 133 JAPAN: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE, BY TYPE, 2023?2030 (USD MILLION) 191
TABLE 134 JAPAN: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2023?2030 (USD MILLION) 192
TABLE 135 JAPAN: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,
2023?2030 (USD MILLION) 192
TABLE 136 JAPAN: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,
2023?2030 (USD MILLION) 193
TABLE 137 JAPAN: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023?2030 (USD MILLION) 193
TABLE 138 CHINA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,
2023?2030 (USD MILLION) 194
TABLE 139 CHINA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE, BY TYPE, 2023?2030 (USD MILLION) 195
TABLE 140 CHINA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2023?2030 (USD MILLION) 195
TABLE 141 CHINA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,
2023?2030 (USD MILLION) 196
TABLE 142 CHINA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,
2023?2030 (USD MILLION) 196
TABLE 143 CHINA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023?2030 (USD MILLION) 197
TABLE 144 INDIA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,
2023?2030 (USD MILLION) 198
TABLE 145 INDIA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE, BY TYPE, 2023?2030 (USD MILLION) 198
TABLE 146 INDIA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2023?2030 (USD MILLION) 198
TABLE 147 INDIA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,
2023?2030 (USD MILLION) 199
TABLE 148 INDIA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,
2023?2030 (USD MILLION) 199
TABLE 149 INDIA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023?2030 (USD MILLION) 200
TABLE 150 SOUTH KOREA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2023?2030 (USD MILLION) 201
TABLE 151 SOUTH KOREA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE,
BY TYPE, 2023?2030 (USD MILLION) 201
TABLE 152 SOUTH KOREA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES,
BY TYPE, 2023?2030 (USD MILLION) 201
TABLE 153 SOUTH KOREA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2023?2030 (USD MILLION) 202
TABLE 154 SOUTH KOREA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2023?2030 (USD MILLION) 202
TABLE 155 SOUTH KOREA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023?2030 (USD MILLION) 203
TABLE 156 AUSTRALIA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,
2023?2030 (USD MILLION) 204
TABLE 157 AUSTRALIA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE,
BY TYPE, 2023?2030 (USD MILLION) 204
TABLE 158 AUSTRALIA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES,
BY TYPE, 2023?2030 (USD MILLION) 204
TABLE 159 AUSTRALIA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,
2023?2030 (USD MILLION) 205
TABLE 160 AUSTRALIA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,
2023?2030 (USD MILLION) 205
TABLE 161 AUSTRALIA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023?2030 (USD MILLION) 206
TABLE 162 REST OF ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET,
BY OFFERING, 2023?2030 (USD MILLION) 207
TABLE 163 REST OF ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE, BY TYPE, 2023?2030 (USD MILLION) 207
TABLE 164 REST OF ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2023?2030 (USD MILLION) 207
TABLE 165 REST OF ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET,
BY FUNCTION, 2023?2030 (USD MILLION) 208
TABLE 166 REST OF ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET,
BY END USER, 2023?2030 (USD MILLION) 208
TABLE 167 REST OF ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023?2030 (USD MILLION) 209
TABLE 168 LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 210
TABLE 169 LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2023?2030 (USD MILLION) 210
TABLE 170 LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE,
BY TYPE, 2023?2030 (USD MILLION) 211
TABLE 171 LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES,
BY TYPE, 2023?2030 (USD MILLION) 211
TABLE 172 LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2023?2030 (USD MILLION) 212
TABLE 173 LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2023?2030 (USD MILLION) 212
TABLE 174 LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023?2030 (USD MILLION) 213
TABLE 175 BRAZIL: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,
2023?2030 (USD MILLION) 214
TABLE 176 BRAZIL: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE,
BY TYPE, 2023?2030 (USD MILLION) 214
TABLE 177 BRAZIL: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES,
BY TYPE, 2023?2030 (USD MILLION) 214
TABLE 178 BRAZIL: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,
2023?2030 (USD MILLION) 215
TABLE 179 BRAZIL: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,
2023?2030 (USD MILLION) 215
TABLE 180 BRAZIL: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023?2030 (USD MILLION) 216
TABLE 181 MEXICO: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,
2023?2030 (USD MILLION) 217
TABLE 182 MEXICO: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE, BY TYPE, 2023?2030 (USD MILLION) 217
TABLE 183 MEXICO: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2023?2030 (USD MILLION) 217
TABLE 184 MEXICO: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,
2023?2030 (USD MILLION) 218
TABLE 185 MEXICO: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,
2023?2030 (USD MILLION) 218
TABLE 186 MEXICO: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023?2030 (USD MILLION) 219
TABLE 187 REST OF LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET,
BY OFFERING, 2023?2030 (USD MILLION) 220
TABLE 188 REST OF LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE, BY TYPE, 2023?2030 (USD MILLION) 220
TABLE 189 REST OF LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2023?2030 (USD MILLION) 220
TABLE 190 REST OF LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET,
BY FUNCTION, 2023?2030 (USD MILLION) 221
TABLE 191 REST OF LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET,
BY END USER, 2023?2030 (USD MILLION) 221
TABLE 192 REST OF LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET
FOR HEALTHCARE PROVIDERS, BY TYPE, 2023?2030 (USD MILLION) 222
TABLE 193 MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET,
BY COUNTRY, 2023?2030 (USD MILLION) 223
TABLE 194 MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET,
BY OFFERING, 2023?2030 (USD MILLION) 223
TABLE 195 MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET
FOR SOFTWARE, BY TYPE, 2023?2030 (USD MILLION) 224
TABLE 196 MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET
FOR SERVICES, BY TYPE, 2023?2030 (USD MILLION) 224
TABLE 197 MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET,
BY FUNCTION, 2023?2030 (USD MILLION) 225
TABLE 198 MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET,
BY END USER, 2023?2030 (USD MILLION) 225
TABLE 199 MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023?2030 (USD MILLION) 226
TABLE 200 GCC COUNTRIES: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2023?2030 (USD MILLION) 227
TABLE 201 GCC COUNTRIES: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE, BY TYPE, 2023?2030 (USD MILLION) 227
TABLE 202 GCC COUNTRIES: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES,
BY TYPE, 2023?2030 (USD MILLION) 227
TABLE 203 GCC COUNTRIES: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2023?2030 (USD MILLION) 228
TABLE 204 GCC COUNTRIES: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2023?2030 (USD MILLION) 228
TABLE 205 GCC COUNTRIES: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023?2030 (USD MILLION) 229
TABLE 206 SAUDI ARABIA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2023?2030 (USD MILLION) 230
TABLE 207 SAUDI ARABIA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE,
BY TYPE, 2023?2030 (USD MILLION) 230
TABLE 208 SAUDI ARABIA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES,
BY TYPE, 2023?2030 (USD MILLION) 230
TABLE 209 SAUDI ARABIA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2023?2030 (USD MILLION) 231
TABLE 210 SAUDI ARABIA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2023?2030 (USD MILLION) 231
TABLE 211 SAUDI ARABIA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023?2030 (USD MILLION) 232
TABLE 212 UAE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,
2023?2030 (USD MILLION) 233
TABLE 213 UAE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE,
BY TYPE, 2023?2030 (USD MILLION) 233
TABLE 214 UAE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES,
BY TYPE, 2023?2030 (USD MILLION) 233
TABLE 215 UAE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,
2023?2030 (USD MILLION) 234
TABLE 216 UAE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,
2023?2030 (USD MILLION) 234
TABLE 217 UAE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023?2030 (USD MILLION) 235
TABLE 218 REST OF GCC COUNTRIES: PATIENT EXPERIENCE TECHNOLOGY MARKET,
BY OFFERING, 2023?2030 (USD MILLION) 235
TABLE 219 REST OF GCC COUNTRIES: PATIENT EXPERIENCE TECHNOLOGY MARKET
FOR SOFTWARE, BY TYPE, 2023?2030 (USD MILLION) 236
TABLE 220 REST OF GCC COUNTRIES: PATIENT EXPERIENCE TECHNOLOGY MARKET
FOR SERVICES, BY TYPE, 2023?2030 (USD MILLION) 236
TABLE 221 REST OF GCC COUNTRIES: PATIENT EXPERIENCE TECHNOLOGY MARKET,
BY FUNCTION, 2023?2030 (USD MILLION) 236
TABLE 222 REST OF GCC COUNTRIES: PATIENT EXPERIENCE TECHNOLOGY MARKET,
BY END USER, 2023?2030 (USD MILLION) 237
TABLE 223 REST OF GCC COUNTRIES: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023?2030 (USD MILLION) 237
TABLE 224 SOUTH AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2023?2030 (USD MILLION) 238
TABLE 225 SOUTH AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE,
BY TYPE, 2023?2030 (USD MILLION) 239
TABLE 226 SOUTH AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES,
BY TYPE, 2023?2030 (USD MILLION) 239
TABLE 227 SOUTH AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2023?2030 (USD MILLION) 239
TABLE 228 SOUTH AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2023?2030 (USD MILLION) 240
TABLE 229 SOUTH AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023?2030 (USD MILLION) 240
TABLE 230 REST OF MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET,
BY OFFERING, 2023?2030 (USD MILLION) 241
TABLE 231 REST OF MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE, BY TYPE, 2023?2030 (USD MILLION) 241
TABLE 232 REST OF MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2023?2030 (USD MILLION) 242
TABLE 233 REST OF MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET,
BY FUNCTION, 2023?2030 (USD MILLION) 242
TABLE 234 REST OF MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET,
BY END USER, 2023?2030 (USD MILLION) 243
TABLE 235 REST OF MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023?2030 (USD MILLION) 243
TABLE 236 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PATIENT EXPERIENCE TECHNOLOGY MARKET, JANUARY 2022?SEPTEMBER 2025 244
TABLE 237 PATIENT EXPERIENCE TECHNOLOGY MARKET: DEGREE OF COMPETITION 248
TABLE 238 PATIENT EXPERIENCE TECHNOLOGY MARKET: REGION FOOTPRINT 255
TABLE 239 PATIENT EXPERIENCE TECHNOLOGY MARKET: OFFERING FOOTPRINT 256
TABLE 240 PATIENT EXPERIENCE TECHNOLOGY MARKET: FUNCTION FOOTPRINT 257
TABLE 241 PATIENT EXPERIENCE TECHNOLOGY MARKET: END-USER FOOTPRINT 258
TABLE 242 PATIENT EXPERIENCE TECHNOLOGY MARKET: DETAILED LIST OF
KEY STARTUPS/SMES 261
TABLE 243 PATIENT EXPERIENCE TECHNOLOGY MARKET: COMPETITIVE
BENCHMARKING OF KEY STARTUPS/SMES 261
TABLE 244 PATIENT EXPERIENCE TECHNOLOGY MARKET: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022?SEPTEMBER 2025 262
TABLE 245 PATIENT EXPERIENCE TECHNOLOGY MARKET: DEALS,
JANUARY 2022?SEPTEMBER 2025 263
TABLE 246 PATIENT EXPERIENCE TECHNOLOGY MARKET: EXPANSIONS,
JANUARY 2022?SEPTEMBER 2025 264
TABLE 247 PRESS GANEY: COMPANY OVERVIEW 265
TABLE 248 PRESS GANEY: SOLUTIONS OFFERED 265
TABLE 249 PRESS GANEY: SOLUTION LAUNCHES AND ENHANCEMENTS,
JANUARY 2022?SEPTEMBER 2025 266
TABLE 250 PRESS GANEY: DEALS, JANUARY 2022?SEPTEMBER 2025 266
TABLE 251 NATIONAL RESEARCH CORPORATION: COMPANY OVERVIEW 268
TABLE 252 NATIONAL RESEARCH CORPORATION: SOLUTIONS OFFERED 269
TABLE 253 NATIONAL RESEARCH CORPORATION: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022?SEPTEMBER 2025 269
TABLE 254 MEDALLIA INC.: COMPANY OVERVIEW 271
TABLE 255 MEDALLIA INC.: SOLUTIONS OFFERED 271
TABLE 256 MEDALLIA INC.: SOLUTION LAUNCHES AND ENHANCEMENTS,
JANUARY 2022?SEPTEMBER 2025 272
TABLE 257 MEDALLIA INC.: DEALS, JANUARY 2022?SEPTEMBER 2025 272
TABLE 258 PHREESIA: COMPANY OVERVIEW 274
TABLE 259 PHREESIA: SOLUTIONS OFFERED 275
TABLE 260 PHREESIA: SOLUTION LAUNCHES AND ENHANCEMENTS,
JANUARY 2022?SEPTEMBER 2025 276
TABLE 261 PHREESIA: DEALS, JANUARY 2022?SEPTEMBER 2025 276
TABLE 262 NICE: COMPANY OVERVIEW 278
TABLE 263 NICE: SOLUTIONS OFFERED 279
TABLE 264 R1: COMPANY OVERVIEW 281
TABLE 265 R1: SOLUTIONS OFFERED 281
TABLE 266 R1: SOLUTION LAUNCHES AND ENHANCEMENTS,
JANUARY 2022?SEPTEMBER 2025 282
TABLE 267 R1: DEALS, JANUARY 2022?SEPTEMBER 2025 282
TABLE 268 EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW 283
TABLE 269 EPIC SYSTEMS CORPORATION: SOLUTIONS OFFERED 283
TABLE 270 EPIC SYSTEMS CORPORATION: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022?SEPTEMBER 2025 284
TABLE 271 EPIC SYSTEMS CORPORATION: DEALS, JANUARY 2022?SEPTEMBER 2025 284
TABLE 272 IQVIA: COMPANY OVERVIEW 285
TABLE 273 IQVIA: SOLUTIONS OFFERED 286
TABLE 274 IQVIA: SOLUTION LAUNCHES AND ENHANCEMENTS,
JANUARY 2022?SEPTEMBER 2025 287
TABLE 275 QUALTRICS: COMPANY OVERVIEW 288
TABLE 276 QUALTRICS: SOLUTIONS OFFERED 288
TABLE 277 QUALTRICS: DEALS, JANUARY 2022?SEPTEMBER 2025 289
TABLE 278 QUALTRICS: EXPANSIONS, JANUARY 2022?SEPTEMBER 2025 290
TABLE 279 QUALTRICS: OTHER DEVELOPMENTS, JANUARY 2022?SEPTEMBER 2025 290
TABLE 280 RELIAS LLC: COMPANY OVERVIEW 291
TABLE 281 RELIAS LLC: SOLUTIONS OFFERED 291
TABLE 282 RELIAS LLC: DEALS, JANUARY 2022?SEPTEMBER 2025 292
TABLE 283 GETWELLNETWORK, INC.: COMPANY OVERVIEW 293
TABLE 284 GETWELLNETWORK, INC.: SOLUTIONS OFFERED 293
TABLE 285 GETWELLNETWORK, INC.: SOLUTION LAUNCHES AND ENHANCEMENTS,
JANUARY 2022?SEPTEMBER 2025 294
TABLE 286 GETWELLNETWORK, INC.: DEALS, JANUARY 2022?SEPTEMBER 2025 294
TABLE 287 CIPHERHEALTH INC.: COMPANY OVERVIEW 295
TABLE 288 CIPHERHEALTH INC.: SOLUTIONS OFFERED 295
TABLE 289 CIPHERHEALTH INC.: SOLUTION LAUNCHES AND ENHANCEMENTS,
JANUARY 2022?SEPTEMBER 2025 296
TABLE 290 CIPHERHEALTH INC.: DEALS, JANUARY 2022?SEPTEMBER 2025 296
TABLE 291 KYRUUS, INC.: COMPANY OVERVIEW 297
TABLE 292 KYRUUS, INC.: SOLUTIONS OFFERED 297
TABLE 293 KYRUUS, INC.: SOLUTION LAUNCHES AND ENHANCEMENTS,
JANUARY 2022?SEPTEMBER 2025 298
TABLE 294 KYRUUS, INC.: DEALS, JANUARY 2022?SEPTEMBER 2025 299
TABLE 295 RELATIENT: COMPANY OVERVIEW 300
TABLE 296 RELATIENT: SOLUTIONS OFFERED 300
TABLE 297 RELATIENT: SOLUTION LAUNCHES AND ENHANCEMENTS,
JANUARY 2022?SEPTEMBER 2025 301
TABLE 298 ALIDA: COMPANY OVERVIEW 302
TABLE 299 ALIDA: SOLUTIONS OFFERED 302
TABLE 300 ALIDA: OTHER DEVELOPMENTS, JANUARY 2022?SEPTEMBER 2025 303
TABLE 301 TWILIO INC.: COMPANY OVERVIEW 304
TABLE 302 TWILIO INC.: SOLUTIONS OFFERED 306
TABLE 303 TWILIO INC.: SOLUTION LAUNCHES AND ENHANCEMENTS,
JANUARY 2022?SEPTEMBER 2025 306
TABLE 304 TWILIO INC.: DEALS, JANUARY 2022?SEPTEMBER 2025 307
TABLE 305 AVAAMO: COMPANY OVERVIEW 308
TABLE 306 AVAAMO: SOLUTIONS OFFERED 308
TABLE 307 AVAAMO: SOLUTION LAUNCHES AND ENHANCEMENTS,
JANUARY 2022?SEPTEMBER 2025 309
TABLE 308 CERTIFY HEALTH: COMPANY OVERVIEW 310
TABLE 309 CERTIFY HEALTH: SOLUTIONS OFFERED 310
TABLE 310 CERTIFY HEALTH: OTHER DEVELOPMENTS, JANUARY 2022?SEPTEMBER 2025 311
TABLE 311 LUMA HEALTH INC.: COMPANY OVERVIEW 312
TABLE 312 LUMA HEALTH INC.: SOLUTIONS OFFERED 312
TABLE 313 LUMA HEALTH INC.: SOLUTION LAUNCHES AND ENHANCEMENTS,
JANUARY 2022?SEPTEMBER 2025 313
TABLE 314 LUMA HEALTH INC.: DEALS, JANUARY 2022?SEPTEMBER 2025 314
TABLE 315 SOLUTIONREACH: COMPANY OVERVIEW 315
TABLE 316 SOLUTIONREACH: SOLUTIONS OFFERED 315
TABLE 317 SOLUTIONREACH: SOLUTION LAUNCHES AND ENHANCEMENTS,
JANUARY 2022?SEPTEMBER 2025 316
TABLE 318 SALESFORCE, INC.: COMPANY OVERVIEW 317
TABLE 319 SALESFORCE, INC.: SOLUTIONS OFFERED 318
TABLE 320 SALESFORCE, INC.: SOLUTION LAUNCHES AND ENHANCEMENTS,
JANUARY 2022?SEPTEMBER 2025 320
TABLE 321 VITAL: COMPANY OVERVIEW 321
TABLE 322 NEXHEALTH: COMPANY OVERVIEW 322
TABLE 323 COLLECTLY, INC.: COMPANY OVERVIEW 323
TABLE 324 BUSINESS INTEGRITY SERVICES: COMPANY OVERVIEW 324
TABLE 325 BAMBOO HEALTH: COMPANY OVERVIEW 325FIGURE 1 PATIENT EXPERIENCE TECHNOLOGY MARKET SEGMENTATION
AND REGIONAL SCOPE 31
FIGURE 2 RESEARCH DESIGN 36
FIGURE 3 PRIMARY SOURCES 38
FIGURE 4 INSIGHTS FROM INDUSTRY EXPERTS 40
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 40
FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 41
FIGURE 7 SUPPLY-SIDE MARKET ESTIMATION 43
FIGURE 8 PATIENT EXPERIENCE TECHNOLOGY MARKET: REVENUE ESTIMATION APPROACH 43
FIGURE 9 BOTTOM-UP APPROACH 45
FIGURE 10 CAGR PROJECTIONS FROM MARKET DYNAMICS, 2025?2030 47
FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 48
FIGURE 12 TOP-DOWN APPROACH 48
FIGURE 13 DATA TRIANGULATION METHODOLOGY 49
FIGURE 14 PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,
2025 VS. 2030 (USD MILLION) 53
FIGURE 15 PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,
2025 VS. 2030 (USD MILLION) 54
FIGURE 16 PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,
2025 VS. 2030 (USD MILLION) 55
FIGURE 17 PATIENT EXPERIENCE TECHNOLOGY MARKET: GEOGRAPHICAL SNAPSHOT 56
FIGURE 18 INCREASING FOCUS ON PATIENT-CENTERED CARE TO DRIVE MARKET 57
FIGURE 19 SOFTWARE SEGMENT AND US LED NORTH AMERICAN MARKET IN 2025 58
FIGURE 20 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 59
FIGURE 21 EMERGING MARKETS TO GROW AT HIGHER CAGR DURING FORECAST PERIOD 60
FIGURE 22 PATIENT EXPERIENCE TECHNOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 61
FIGURE 23 PATIENT EXPERIENCE TECHNOLOGY MARKET: TRENDS/DISRUPTIONS
IMPACTING CUSTOMERS’ BUSINESSES 71
FIGURE 24 AVERAGE SELLING PRICE TREND OF PATIENT EXPERIENCE TECHNOLOGY,
BY REGION, 2022?2025 (USD) 73
FIGURE 25 PATIENT EXPERIENCE TECHNOLOGY MARKET: VALUE CHAIN ANALYSIS 74
FIGURE 26 PATIENT EXPERIENCE TECHNOLOGY MARKET: ECOSYSTEM ANALYSIS 76
FIGURE 27 RECENT FUNDING OF PLAYERS IN PATIENT EXPERIENCE TECHNOLOGY MARKET 78
FIGURE 28 GLOBAL PATENT PUBLICATION TRENDS IN PATIENT EXPERIENCE
TECHNOLOGY, 2015?2025 81
FIGURE 29 JURISDICTION ANALYSIS OF PATIENT EXPERIENCE TECHNOLOGY
PATENTS, JANUARY 2015?AUGUST 2025 82
FIGURE 30 PATIENT EXPERIENCE TECHNOLOGY MARKET: PATENT ANALYSIS,
JANUARY 2015?AUGUST 2025 83
FIGURE 31 PATIENT EXPERIENCE TECHNOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS 98
FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS 100
FIGURE 33 KEY BUYING CRITERIA FOR TOP THREE END USERS 101
FIGURE 34 MARKET POTENTIAL OF AI/GENERATIVE AI IN ENHANCING PATIENT EXPERIENCE TECHNOLOGY ACROSS INDUSTRIES 105
FIGURE 35 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS 107
FIGURE 36 NORTH AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET SNAPSHOT 154
FIGURE 37 ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET SNAPSHOT 187
FIGURE 38 PATIENT EXPERIENCE TECHNOLOGY MARKET: R